ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1602819
The Phenology of Epilobium hirsutum L.: Assessing Marker Compounds Variability of a Pharmaceutically Important Plant Remedy
Provisionally accepted- 1Pharmacognosy and Phytotherapy Group, UCL School of Pharmacy, London, United Kingdom
- 2Pharmaceutical Chemistry Department, National University of Pharmacy, Kharkiv, Ukraine
- 3Department of Pharmaceutical Biology, Kiel University, Kiel, Schleswig-Holstein, Germany
- 4Nature Research Centre, Laboratory of Flora and Geobotany, Vilnius, Lithuania
- 5Zhytomyr Basic Pharmaceutical Professional College, Zhytomyr, Ukraine
- 6Department of Analytical and Toxicological Chemistry, Lithuanian University of Health Sciences, Kaunas, Lithuania
- 7Department of Pharmaceutical Sciences and Chinese Medicine Resources, Chinese Medicine Research Center, College of Chinese Medicine, China Medical Universit, Taichung, Taiwan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Epilobium hirsutum L. (Onagraceae), a perennial medicinal plant, has considerable pharmaceutical value due to its phenolic acids, flavonoids, and ellagitannins, including oenothein A and B. The plant is reported to have therapeutic benefits for several conditions, such as prostate gland, bladder, and hormonal disorders. This study aimed to provide evidence-based data on the chemical composition of the species over a one-year cycle and define the optimal harvesting period, which is essential to ensure consistency and efficacy in plant-derived products.The phytochemical variability of E. hirsutum across habitats (mesic grassland, wet grassland, and lake shore), plant parts (leaves and stems), and phenological stages (from April to October) was investigated. Using HPLC and HPTLC methods, 11 pharmacologically active marker compounds were quantified in 78 samples collected every two weeks during 2023.Results: Among the hydroxycinnamic acids, chlorogenic acid was dominant in samples from shaded habitats, with maximum accumulation in samples from leaves during the vegetative phase (up to 2.25 mg/g DW). Flavonoids such as isoquercitrin and hyperoside peaked in leaves from the lake shore and wet grassland habitats during flowering. Oenothein B, a major ellagitannin, showed the highest concentrations in wet grassland leaves during flowering (73.97 mg/g DW).This study is the first to integrate habitat, phenology, and plant part data to characterise seasonal dynamics of key marker compounds in E. hirsutum under natural east-part of the UK conditions. Shaded, moist habitats were found to promote higher biosynthesis of secondary metabolites, whereas open, dry conditions favoured biomass yield. Distinct seasonal patterns in the accumulation of β-hydroxycinnamic acids and ellagitannins provide insight into their physiological functions and potential pharmacological significance. By identifying the dynamics of marker compounds and optimal harvesting periods, the study provides a framework for sustainable industrial practices for pharmaceutical raw material production and supports standardisation in herbal production.
Keywords: Epilobium hirsutum, phenolic compounds, HPTLC, HPLC, Marker compounds, Phytochemical variability, phenology, industrial crops
Received: 30 Mar 2025; Accepted: 05 Jun 2025.
Copyright: © 2025 Mykhailenko, Jalil, Gudžinskas, Uminska, Ivanauskas and Heinrich. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Olha Mykhailenko, Pharmacognosy and Phytotherapy Group, UCL School of Pharmacy, London, United Kingdom
Michael Heinrich, Pharmacognosy and Phytotherapy Group, UCL School of Pharmacy, London, United Kingdom
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.